GlassScriptPhysician profile
Stephanie Leigh Arnold
NPI 1366024457
$1,139.24
in general payments reported to CMS, 2019-2025
13 companies · $307 in 2025
The $307 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $120 · 2022: $235 · 2023: $191 · 2024: $286 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $784.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $784.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $236.81 | 2024-2025 | |
| Myovant Sciences INC. | $127.82 | 2022 | |
| Sumitomo Pharma America, INC. | $125.00 | 2023 | Myfembree |
| Cardiovascular Systems INC. | $120.09 | 2021 | |
| Philips North America LLC | $119.27 | 2024 | (Bh4) Igt Devices Undivided |
| Becton, Dickinson and Company | $107.00 | 2022 | |
| Hologic Sales and Service, LLC | $100.63 | 2024-2025 | Aptima, Myosure Tissue Removal Device, Novasure |
| Baxter Healthcare | $55.51 | 2024-2025 | Perclot |
| Minerva Surgical, INC | $51.85 | 2023 | |
| Organon LLC | $31.47 | 2024 | |
| Supernus Pharmaceuticals, INC. | $24.80 | 2025 | Qelbree |
| Sage Therapeutics, LLC | $24.80 | 2025 | Zurzuvae |
| Axonics, INC. | $14.19 | 2023 | Bulkamid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Arnold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.